The International Medical Advisory Panel (IMAP) is a body of medical scientists and technical experts with a mandate to formulate and disseminate recommendations to IPPF and other interested parties regarding best practices in sexual and reproductive health (SRH) care and family planning.

These recommendations address relevant programmatic, training and service delivery issues.

The expertise of IMAP members includes contraceptive technology, obstetrics and gynaecology, endocrinology, public health, epidemiology and family planning programme management.

Many are clinical practitioners and distinguished academics, some bring invaluable experience from international research and development agencies.

Members are drawn from all parts of the world, and a system of rotational membership ensures regular infusions of varied experience and expertise.

Panel experts have access to the latest research findings on contraceptive safety and efficacy, both published and unpublished, so that the Panel's advice is based on the best possible evidence.

The Panel usually meets twice a year and its views and advice on methods of fertility regulation and other sexual and reproductive health issues are disseminated in the form of IMAP Statements and sent regularly to all Member Associations. 

The Panel currently consists of eight members appointed by the IPPF Governing Council and representatives from the World Health Organization (WHO) and the United Nations Population Fund.

Representatives from professional organisations such as the International Federation of Gynaecology and Obstetrics are also invited to attend meetings.